Open AccessImpact of total body weight on rate of acute kidney injury in patients treated with piperacillin–tazobactam and vancomycin
Author(s) -
W. Cliff Rutter,
Ronald G. Hall,
David S. Burgess
Publication year - 2019
Publication title -
american journal of health-system pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 96
eISSN - 1535-2900
pISSN - 1079-2082
DOI - 10.1093/ajhp/zxz120
Subject(s) - piperacillin/tazobactam , medicine , tazobactam , piperacillin , acute kidney injury , vancomycin , anesthesia , body weight , intensive care medicine , staphylococcus aureus , biology , bacteria , genetics , pseudomonas aeruginosa
Results of a study to determine whether obesity is associated with acute kidney injury (AKI) among patients receiving combination therapy with piperacillin-tazobactam and vancomycin are reported.